DE LAURENTIIS, MICHELINO
DE LAURENTIIS, MICHELINO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Manuale di Oncologia Clinica
1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?
1994 C. L., Loprinzi; P. M., Ravdin; DE LAURENTIIS, Michelino; P., Novotny
Prognostic factors in human colorectal cancer.
1997 A. R., Bianco; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; G., Tortora; F., Ciardiello
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
2011 Davies, C; Godwin, J; Gray, R; Clarke, M; Cutter, D; Darby, S; Mcgale, P; Pan, Hc; Taylor, C; Wang, Yc; Dowsett, M; Ingle, J; Peto, R; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.
2008 Clarke, M; Coates, As; Darby, Sc; Davies, C; Gelber, Rd; Godwin, J; Goldhirsch, A; Gray, R; Peto, R; Pritchard, Ki; Wood, Wc; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
A-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies.
1996 Caraglia, M.; Leardi, A.; Ricciardi, B.; DE LAURENTIIS, Michelino; Lentini, M. L.; Graziano, ; Matano, Elide; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Tagliaferri, P.
Targeted Therapy of Breast Cancer
2009 DE LAURENTIIS, Michelino; Zielinski, C.
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies
2002 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco
NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA
2000 Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A.
2000 Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.
2008 Metro, G.; Fabi, A.; Russillo, M.; Papaldo, P.; DE LAURENTIIS, Michelino; Ferretti, G.; Pellegrini, D.; Nuzzo, C.; Graziano, V.; Vici, P.; Introna, M.; Felici, A.; Cognetti, F.; Carlini, P.
Prognostic factors: rationale and methods of analysis and integration.
1994 G. M., Clark; S. G., Hilsenbeck; P. M., Ravdin; DE LAURENTIIS, Michelino; C. K., Osborne
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.
2007 DI LORENZO, G; Autorino, R; Perdona, S; DE LAURENTIIS, Michelino; D'Armiento, FRANCESCO PAOLO; Cancello, G; Mirone, Vincenzo; Imbimbo, Ciro; Longo, Nicola; Altieri, Vincenzo; Tortora, Giampaolo; Figg, Wd; DE PLACIDO, Sabino
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
2009 E., Montagna; G., Cancello; D., D'Agostino; Lauria, Rossella; Forestieri, Valeria; A., Esposito; L., Silvestro; Accurso, Antonello; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino
TAG-72 expression and clinical outcome in primary breast cancer.
1999 C., Pizzi; A., Sgambato; DE LAURENTIIS, Michelino; Limite, Gennaro; L., Panico; Pettinato, Guido; R., Muraro; L., Tauchmanova; A., Galietta; A. R., Bianco; R., Mariani Costantini; A., Contegiacomo
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
1996 Carlomagno, Chiara; F., Perrone; C., Gallo; DE LAURENTIIS, Michelino; R., Lauria; A., Morabito; Pettinato, Guido; L., Panico; A., D'Antonio; A. R., Bianco; DE PLACIDO, Sabino
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
1997 Fontanini, G.; Lucchi, M.; Vignati, S.; Mussi, A.; Ciardiello, F.; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Survival, quality of life and breast cancer.
2001 Mosconi, P; Colozza, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Maltoni, M.
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.
2004 DE PLACIDO, Sabino; Scambia, G; DI VAGNO, G; Naglieri, E; Lombardi, Av; Biamonte, R; Marinaccio, M; Carteni, G; Manzione, L; Febbraro, A; DE MATTEIS, A; Gasparini, G; Valerio, Mr; Danese, S; Perrone, F; Lauria, Rossella; DE LAURENTIIS, Michelino; Greggi, S; Gallo, C; Pignata, S.
External beam radiotherapy in bone metastatic prostate cancer: impact on patients’ pain relief and quality of life.
2003 DI LORENZO, G; Autorino, R; Ciardiello, F; Raben, D; Bianco, C; Troiani, T; Pizza, C; DE LAURENTIIS, Michelino; Pensabene, M; D., ARMIENTO M; Bianco, Ar; DE PLACIDO, Sabino
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Manuale di Oncologia Clinica | 2.1 Contributo in volume (Capitolo o Saggio) | 1996 | Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo | |
| Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? | 1.1 Articolo in rivista | 1994 | C. L., Loprinzi; P. M., Ravdin; DE LAURENTIIS, Michelino; P., Novotny | |
| Prognostic factors in human colorectal cancer. | 1.1 Articolo in rivista | 1997 | A. R., Bianco; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; G., Tortora; F., Ciardiello | |
| Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. | 1.1 Articolo in rivista | 2011 | Davies, C; Godwin, J; Gray, R; Clarke, M; Cutter, D; Darby, S; Mcgale, P; Pan, Hc; Taylor, C; Wang, Yc; Dowsett, M; Ingle, J; Peto, R; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. | 1.1 Articolo in rivista | 2008 | Clarke, M; Coates, As; Darby, Sc; Davies, C; Gelber, Rd; Godwin, J; Goldhirsch, A; Gray, R; Peto, R; Pritchard, Ki; Wood, Wc; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| A-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies. | 1.1 Articolo in rivista | 1996 | Caraglia, M.; Leardi, A.; Ricciardi, B.; DE LAURENTIIS, Michelino; Lentini, M. L.; Graziano, ; Matano, Elide; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Tagliaferri, P. | |
| Targeted Therapy of Breast Cancer | 8.01 Chairman di Sessioni di Convegni Internazionali | 2009 | DE LAURENTIIS, Michelino; Zielinski, C. | |
| HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies | 1.5 Abstract in rivista | 2002 | DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco | |
| NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA | 1.1 Articolo in rivista | 2000 | Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule. | 1.1 Articolo in rivista | 2008 | Metro, G.; Fabi, A.; Russillo, M.; Papaldo, P.; DE LAURENTIIS, Michelino; Ferretti, G.; Pellegrini, D.; Nuzzo, C.; Graziano, V.; Vici, P.; Introna, M.; Felici, A.; Cognetti, F.; Carlini, P. | |
| Prognostic factors: rationale and methods of analysis and integration. | 1.1 Articolo in rivista | 1994 | G. M., Clark; S. G., Hilsenbeck; P. M., Ravdin; DE LAURENTIIS, Michelino; C. K., Osborne | |
| Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study. | 1.1 Articolo in rivista | 2007 | DI LORENZO, G; Autorino, R; Perdona, S; DE LAURENTIIS, Michelino; D'Armiento, FRANCESCO PAOLO; Cancello, G; Mirone, Vincenzo; Imbimbo, Ciro; Longo, Nicola; Altieri, Vincenzo; Tortora, Giampaolo; Figg, Wd; DE PLACIDO, Sabino | |
| Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. | 1.1 Articolo in rivista | 2009 | E., Montagna; G., Cancello; D., D'Agostino; Lauria, Rossella; Forestieri, Valeria; A., Esposito; L., Silvestro; Accurso, Antonello; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino | |
| TAG-72 expression and clinical outcome in primary breast cancer. | 1.1 Articolo in rivista | 1999 | C., Pizzi; A., Sgambato; DE LAURENTIIS, Michelino; Limite, Gennaro; L., Panico; Pettinato, Guido; R., Muraro; L., Tauchmanova; A., Galietta; A. R., Bianco; R., Mariani Costantini; A., Contegiacomo | |
| c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. | 1.1 Articolo in rivista | 1996 | Carlomagno, Chiara; F., Perrone; C., Gallo; DE LAURENTIIS, Michelino; R., Lauria; A., Morabito; Pettinato, Guido; L., Panico; A., D'Antonio; A. R., Bianco; DE PLACIDO, Sabino | |
| Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. | 1.1 Articolo in rivista | 1997 | Fontanini, G.; Lucchi, M.; Vignati, S.; Mussi, A.; Ciardiello, F.; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Survival, quality of life and breast cancer. | 1.1 Articolo in rivista | 2001 | Mosconi, P; Colozza, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Maltoni, M. | |
| Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study. | 1.1 Articolo in rivista | 2004 | DE PLACIDO, Sabino; Scambia, G; DI VAGNO, G; Naglieri, E; Lombardi, Av; Biamonte, R; Marinaccio, M; Carteni, G; Manzione, L; Febbraro, A; DE MATTEIS, A; Gasparini, G; Valerio, Mr; Danese, S; Perrone, F; Lauria, Rossella; DE LAURENTIIS, Michelino; Greggi, S; Gallo, C; Pignata, S. | |
| External beam radiotherapy in bone metastatic prostate cancer: impact on patients’ pain relief and quality of life. | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | DI LORENZO, G; Autorino, R; Ciardiello, F; Raben, D; Bianco, C; Troiani, T; Pizza, C; DE LAURENTIIS, Michelino; Pensabene, M; D., ARMIENTO M; Bianco, Ar; DE PLACIDO, Sabino |